Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 5, 1998

View Archived Issues

COX-2 inhibitors reported by UPSA

Polypeptide-chelating agent complexes reported by Novartis

Native calcitonin mimetics from ZymoGenetics

Anti-GnRH immunogens disclosed by Aphton

QLT PhotoTherapeutics: Q3 1997 highlights

Company Profile: Teva

Structurally distinct vitamin D analogues from Leo

Antiamnesic compounds described by Gedeon Richter

NOS inhibitors prepared at Ono

Antifungal agents prepared at Pola

Abelcet now approved in 18 countries

Enrollment complete in pivotal trial of P829 for lung cancer imaging

MMP inhibitor developed at Chiroscience enters clinical trials for cancer

Biomatrix's Hyalform approved in additional markets; PMA resubmission planned in U.S.

Oral ganciclovir tested for prevention of CMV disease in transplant recipients

Synaptic, Merck & Co. extend BPH research agreement

Antiplatelet effects of policosanol, aspirin and policosanol + aspirin in humans

FDA approves first gene-based cancer diagnostic for U.S. market

Clinical pharmacodynamic profile of 5-HT4 agonist

Indian scientists demonstrate protective effect of NAP against stress organ injury in malaria

Lubeluzole improves clinical outcome in stroke patients

Mechanism of TNF-alpha production in tumor tissues by Ono-4007

Nootropic agent evaluated for the treatment of stroke

Anika files for U.S. approval of osteoarthritis Rx

GR-144053 enhances suppression of neointima formation by losartan following vascular injury

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...